PMC:7247521 / 25290-28994 11 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T283 | 36-45 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T284 | 94-98 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T285 | 153-162 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T286 | 438-447 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T287 | 590-594 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T288 | 641-650 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T289 | 714-730 | UBERON:0005409 | denotes | gastrointestinal |
| T290 | 1055-1064 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T291 | 1120-1125 | CL_1 | denotes | Caco2 |
| T292 | 1127-1133 | CL_1 | denotes | Caco-2 |
| T293 | 1152-1162 | UBERON:0000160 | denotes | Intestinal |
| T294 | 1175-1180 | SP_6;NCBITaxon:9606 | denotes | Human |
| T295 | 1260-1265 | SP_6;NCBITaxon:9606 | denotes | Human |
| T296 | 1273-1284 | UBERON:0000120 | denotes | Blood Brain |
| T297 | 1307-1310 | UBERON:0001017 | denotes | CNS |
| T298 | 1312-1334 | UBERON:0001017 | denotes | Central Nervous System |
| T299 | 1369-1373 | PR:000013036 | denotes | OCT2 |
| T300 | 1375-1380 | UBERON:0002113 | denotes | Renal |
| T301 | 1381-1395 | CHEBI:25697;CHEBI:25697;PR:000014988 | denotes | Organic Cation |
| T302 | 1396-1409 | PR:000014988 | denotes | Transporter 2 |
| T303 | 1462-1467 | SP_6;NCBITaxon:9606 | denotes | Human |
| T304 | 1470-1474 | PR:P11308 | denotes | hERG |
| T305 | 1481-1485 | PR:P11308 | denotes | hERG |
| T306 | 1513-1517 | UBERON:0000165 | denotes | Oral |
| T307 | 1518-1521 | NCBITaxon:10114 | denotes | Rat |
| T308 | 1589-1591 | UBERON:0001448 | denotes | MT |
| T309 | 1818-1827 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T310 | 1850-1858 | SP_7 | denotes | COVID-19 |
| T311 | 1879-1888 | PG_2 | denotes | E protein |
| T312 | 1890-1893 | CHEBI:24870;CHEBI:24870 | denotes | ion |
| T313 | 1914-1919 | PR:000000125 | denotes | nsp13 |
| T314 | 1951-1956 | PR:000000125 | denotes | nsp13 |
| T315 | 2014-2016 | CHEBI:15379;CHEBI:15379 | denotes | O2 |
| T342 | 2108-2117 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T343 | 2151-2155 | UBERON:0000165 | denotes | oral |
| T344 | 2191-2197 | CL_1 | denotes | Caco-2 |
| T345 | 2248-2252 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T346 | 2298-2307 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T347 | 2323-2329 | UBERON:0000479 | denotes | tissue |
| T348 | 2343-2349 | UBERON:0000479 | denotes | tissue |
| T349 | 2364-2370 | UBERON:0001969 | denotes | plasma |
| T350 | 2452-2467 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological |
| T351 | 2539-2558 | UBERON:0000120 | denotes | blood-brain barrier |
| T352 | 2560-2563 | UBERON:0000120 | denotes | BBB |
| T353 | 2569-2591 | UBERON:0001017 | denotes | central nervous system |
| T354 | 2593-2596 | UBERON:0001017 | denotes | CNS |
| T355 | 2615-2624 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T356 | 2642-2647 | UBERON:0002113 | denotes | renal |
| T357 | 2691-2696 | UBERON:0002113 | denotes | renal |
| T358 | 2697-2711 | CHEBI:25697;CHEBI:25697;PR:000014988 | denotes | organic cation |
| T359 | 2712-2725 | PR:000014988 | denotes | transporter 2 |
| T360 | 2727-2731 | PR:000013036 | denotes | OCT2 |
| T361 | 2746-2755 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T362 | 2815-2819 | CHEBI:34018;CHEBI:34018 | denotes | AMES |
| T363 | 2854-2858 | PR:P11308 | denotes | hERG |
| T364 | 2861-2870 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T365 | 2872-2876 | PR:P11308 | denotes | hERG |
| T366 | 2880-2889 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T367 | 2891-2895 | UBERON:0000165 | denotes | oral |
| T368 | 2896-2899 | NCBITaxon:10114 | denotes | rat |
| T372 | 3018-3027 | CHEBI:36357;CHEBI:36357 | denotes | compounds |